Wealth Alliance Sells 340 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Wealth Alliance lessened its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 38.2% in the fourth quarter, HoldingsChannel reports. The firm owned 550 shares of the biotechnology company’s stock after selling 340 shares during the period. Wealth Alliance’s holdings in Axon Enterprise were worth $327,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in AXON. Prestige Wealth Management Group LLC increased its holdings in Axon Enterprise by 115.8% in the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after purchasing an additional 44 shares during the last quarter. New Wave Wealth Advisors LLC bought a new stake in Axon Enterprise in the fourth quarter valued at about $40,000. Brooklyn Investment Group bought a new stake in Axon Enterprise in the third quarter valued at about $41,000. Y.D. More Investments Ltd bought a new stake in Axon Enterprise in the fourth quarter valued at about $45,000. Finally, Planning Capital Management Corp increased its holdings in Axon Enterprise by 83.3% in the third quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock valued at $48,000 after purchasing an additional 55 shares during the last quarter. Institutional investors own 79.08% of the company’s stock.

Insider Activity at Axon Enterprise

In related news, insider Jeffrey C. Kunins sold 2,304 shares of the stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $654.79, for a total transaction of $1,508,636.16. Following the completion of the transaction, the insider now directly owns 128,542 shares of the company’s stock, valued at approximately $84,168,016.18. This represents a 1.76 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the transaction, the director now directly owns 6,929 shares of the company’s stock, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 8,711 shares of company stock valued at $5,631,561. Insiders own 6.10% of the company’s stock.

Axon Enterprise Stock Down 5.3 %

AXON stock opened at $513.22 on Friday. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The stock has a market capitalization of $39.13 billion, a P/E ratio of 132.62, a P/E/G ratio of 5.95 and a beta of 1.05. The business has a 50-day moving average of $619.94 and a 200-day moving average of $517.11. Axon Enterprise, Inc. has a fifty-two week low of $265.32 and a fifty-two week high of $715.99.

Analyst Ratings Changes

A number of equities research analysts recently commented on AXON shares. Needham & Company LLC upped their price objective on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a report on Friday, November 8th. Northcoast Research downgraded Axon Enterprise from a “buy” rating to a “neutral” rating in a report on Wednesday. Robert W. Baird increased their price target on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. The Goldman Sachs Group increased their price target on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a report on Monday, January 27th. Finally, Northland Securities increased their price target on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a report on Monday, November 11th. Three equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $561.31.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.